These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 26711206

  • 1. [CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract].
    Yue C, Piao Y, Bai Y, Liu H, Zhang L.
    Zhonghua Yi Xue Za Zhi; 2015 Aug 11; 95(30):2447-50. PubMed ID: 26711206
    [Abstract] [Full Text] [Related]

  • 2. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT, Jordan RC, Berean KW, Perez-Ordoñez B.
    J Clin Pathol; 2004 Sep 11; 57(9):932-7. PubMed ID: 15333652
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG, Shah R, Connolly LE, McBride HA.
    Int J Gynecol Pathol; 2008 Jan 11; 27(1):92-100. PubMed ID: 18156982
    [Abstract] [Full Text] [Related]

  • 5. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R, Haltas H, Yenidunya S.
    Diagn Pathol; 2012 Jan 23; 7():9. PubMed ID: 22268990
    [Abstract] [Full Text] [Related]

  • 6. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract.
    Franchi A, Massi D, Palomba A, Biancalani M, Santucci M.
    Virchows Arch; 2004 Jul 23; 445(1):63-7. PubMed ID: 15175880
    [Abstract] [Full Text] [Related]

  • 7. Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation.
    Park KJ, Bramlage MP, Ellenson LH, Pirog EC.
    Appl Immunohistochem Mol Morphol; 2009 Jan 23; 17(1):8-11. PubMed ID: 18776815
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.
    Jpn J Clin Oncol; 2010 Mar 23; 40(3):208-13. PubMed ID: 19926591
    [Abstract] [Full Text] [Related]

  • 11. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT.
    Cancer; 2001 Oct 25; 93(5):330-6. PubMed ID: 11668468
    [Abstract] [Full Text] [Related]

  • 12. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma.
    Ortiz-Rey JA, Alvarez C, San Miguel P, Iglesias B, Antón I.
    Appl Immunohistochem Mol Morphol; 2005 Jun 25; 13(2):142-6. PubMed ID: 15894926
    [Abstract] [Full Text] [Related]

  • 13. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM, Meir A, Sabo E.
    Int J Gynecol Pathol; 2004 Jan 25; 23(1):52-7. PubMed ID: 14668551
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM, Lin DM, Lü N, Liu XY, Wen P, Liu FS.
    Zhonghua Yi Xue Za Zhi; 2003 Aug 10; 83(15):1350-2. PubMed ID: 12930693
    [Abstract] [Full Text] [Related]

  • 17. [Sinonasal adenocarcinomas reviewed. Prognostic value of WHO 2005 histological classification].
    El Ayoubi A, Poizat F, Garrel R, Costes V, Guerrier B, Essakalli L, Kzadri M, Crampette L.
    Ann Otolaryngol Chir Cervicofac; 2009 Sep 10; 126(4):175-81. PubMed ID: 19591973
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma.
    Sree UD, Prayaga AK, R Reddy VV, Rukmanghadha N, Chowhan AK, Phaneendra BV.
    Indian J Pathol Microbiol; 2022 Sep 10; 65(1):42-48. PubMed ID: 35074964
    [Abstract] [Full Text] [Related]

  • 20. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2.
    Cathro HP, Mills SE.
    Am J Surg Pathol; 2004 Aug 10; 28(8):1026-32. PubMed ID: 15252308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.